openPR Logo
Press release

Eliquis Market Growth Driven by Anticoagulant Therapy Demand and Cardiovascular Disease Burden, 2025-2032 | Pfizer Inc., Bristol-Myers Squibb Company

08-14-2025 08:40 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Eliquis Market

Eliquis Market

The qualitative latest Research report (2025-2032) on the Eliquis Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.

Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/8193

Focused on growth and future opportunities, this report is a go-to resource for industry leaders, investors, and decision-makers. With visuals, charts, and data-driven insights, the Eliquis Market has experienced rapid growth fueled by rising demand and innovation. This analysis gives you the competitive edge with actionable strategies backed by real data.

Industry Insights and Scope of the Eliquis Market

This report provides a comprehensive segmentation of the Eliquis Market scope, covering product types, applications, end-user markets, key regions, and leading competitors. It offers expert insights into current market conditions, historical performance, production trends, and revenue forecasts.

The financial performance of key players is assessed, including gross profits, sales volumes, and manufacturing costs. Analytical tools like SWOT analysis and Porter's Five Forces are used to evaluate market dynamics. Additionally, the report includes a detailed review of major players, covering their financials, product benchmarking, and competitive strategies.

Top Companies Covered In This Eliquis Market Report:

Pfizer Inc. and Bristol-Myers Squibb Company

The Eliquis Market Insights is projected to experience substantial growth during the forecast period from 2025 to 2032. In 2025, the market is expected to expand steadily, with major players increasingly adopting strategic initiatives to drive growth beyond initial forecasts. The competitive analysis highlights key industry players, their innovations, and business strategies. Additionally, the report identifies the most promising long-term growth opportunities and explores the latest advancements in processes and product development.

Buy the Complete Report with an Impressive Discount (Up to 25% Off) at: https://www.coherentmarketinsights.com/insight/buy-now/8193

Comprehensive segmentation and classification of the report:

By Indication: Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation , Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery , Deep Vein Thrombosis , Pulmonary Embolism , Reduction in the Risk of Recurrence of Deep Vein Thrombosis and Pulmonary Embolism , Venous Thromboembolism (VTE) and Reduction in the Risk of Recurrent VTE in Pediatric Patients
By Strength: 2.5 mg and 5 mg
By Age Group: Pediatric and Adult
By Dosage Form: Oral Tablet and Oral Suspension
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

Geographical Landscape of the Eliquis Market:

◘ North America (U.S., Canada, Mexico)
◘ Europe (Germany, U.K., France, Russia, Italy, Spain)
◘ Asia-Pacific (China, India, Japan, Australia, Singapore, NZ)
◘ South America (Argentina, Brazil)
◘ Middle East & Africa (Saudi Arabia, Turkey, UAE, Africa)

Report Drivers and Trends Analysis:

The report also discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Eliquis Market trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.

✅ Key Benefits:

✦ Quantitative analysis of market segments, trends, estimations, and dynamics (2025-2032).
✦ Insights into key drivers, restraints, and opportunities.
✦ Porter's Five Forces analysis for strategic decision-making.
✦ Segmentation analysis to identify market opportunities.
✦ Revenue mapping of major countries by region.
✦ Benchmarking and positioning of market players.
✦ Analysis of regional and global trends, key players, and growth strategies.

Why You Should Buy This Report:

■ The impact of technological advancements and emerging industry trends
■ Regulatory and policy shifts and their implications for stakeholders
■ Competitive landscape analysis, including key player profiles and growth strategies
■ Major market challenges like supply chain issues and evolving consumer behavior
■ Opportunities in new products, applications, and potential investment areas

This report delivers actionable insights via secondary research, direct stakeholder interviews, and expert validation through Coherent Market Insights' extensive regional database.

📌 Get Instant Access! Purchase Research Report and Receive a 25% Discount with limited-time offer: https://www.coherentmarketinsights.com/insight/buy-now/8193

💬 FAQ's

Q.1 What are the main factors influencing the Eliquis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top Eliquis Market companies compare in terms of sales, revenue, and prices?
Q.5 How are market types and applications and deals, revenue, and value explored?
Q.6 What does a business area's assessment of agreements, income, and value implicate?

✍️ PR Authored By:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report.

About Us:

With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

☎️ Contact Us:

533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-8-7924-7805
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Eliquis Market Growth Driven by Anticoagulant Therapy Demand and Cardiovascular Disease Burden, 2025-2032 | Pfizer Inc., Bristol-Myers Squibb Company here

News-ID: 4145057 • Views:

More Releases from Coherent Market Insights

Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Flavored Syrups Market Is Booming So Rapidly Growth by 2032| Starbucks, Fontana, Amoretti, Jordan's Skinny Syrups
Flavored Syrups Market Is Booming So Rapidly Growth by 2032| Starbucks, Fontana, …
The latest study by Coherent Market Insights, titled "Flavored Syrups Market Size, Share & Trends Forecast 2025-2032," offers an in-depth analysis of the global and regional dynamics shaping this rapidly evolving industry. This comprehensive report highlights the competitive landscape, key market segments, value chain analysis, and emerging technological and regulatory trends expected between 2025 and 2032. The report provides actionable insights for business leaders, policymakers, investors, and new market entrants
Gourmet Salts Market Booming with Rapid Growth Through 2032: Himalayan Chef, Morton Salt, Cargill, Diamond Crystal
Gourmet Salts Market Booming with Rapid Growth Through 2032: Himalayan Chef, Mor …
The latest study by Coherent Market Insights, titled "Gourmet Salts Market Size, Share & Trends Forecast 2025-2032," offers an in-depth analysis of the global and regional dynamics shaping this rapidly evolving industry. This comprehensive report highlights the competitive landscape, key market segments, value chain analysis, and emerging technological and regulatory trends expected between 2025 and 2032. The report provides actionable insights for business leaders, policymakers, investors, and new market entrants
Pea Processed Ingredients Market to Witness Strong Growth by 2032 | Emerging Trends and Future Projections | Roquette Frères, Emsland Group, The Green Labs LLC
Pea Processed Ingredients Market to Witness Strong Growth by 2032 | Emerging Tre …
The latest report titled "Pea Processed Ingredients Market" Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032. offering a comprehensive and in-depth analysis of the industry. The report provides key insights into current market trends, growth drivers, challenges, and opportunities shaping the market landscape. It also includes a thorough competitor analysis, regional market evaluation, and recent technological or strategic developments influencing the market trajectory. Currently, the Pea Processed Ingredients Market holds a

All 5 Releases


More Releases for Eliquis

Eliquis Market Size and Share: 2025 Analysis of Rising Business Opportunities wi …
The Eliquis market is witnessing significant industry momentum driven by increasing prevalence of cardiovascular disorders and a growing emphasis on anticoagulant therapies worldwide. Innovations in drug delivery and expanded clinical indications have further amplified the market scope, positioning Eliquis as a pivotal player in managing thromboembolic events. The Global Eliquis Market size is estimated to be valued at USD 7.2 billion in 2025 and is expected to reach USD 10.3
Eliquis Market Thrives with Rising Incidence of Atrial Fibrillation and Stroke P …
The Eliquis market is a critical segment within the anticoagulant therapy domain, witnessing significant advancements due to its expanding application for stroke prevention in atrial fibrillation and treatment of venous thromboembolism. Increasing prevalence of cardiovascular disorders globally has propelled industry share and stimulated product demand across multiple healthcare segments. The Global Eliquis Market size is estimated to be valued at USD 7.90 billion in 2025 and is expected to reach
Apixaban (Eliquis) Manufacturing Plant Project Report 2025: Key Insights and Bus …
Introduction The pharmaceutical sector has consistently been at the forefront of healthcare innovation, developing life-saving medications that cater to diverse medical needs. One such medication is Apixaban (Eliquis), an oral anticoagulant (blood thinner) that has revolutionized the management of conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Manufactured by Bristol-Myers Squibb and Pfizer, Apixaban is used to reduce the risk of stroke and blood clots. Establishing a manufacturing plant
Eliquis Market Latest Technology, Emerging Technology, Historical Demands by Reg …
In 2024, the Wiseguy Reports latest published research report on "Eliquis market growth is growing steadily with exponential rate and a rising adoption of strategies by top industry players, over the projected horizon 2024 to 2032". Eliquis Market share was valued at 13.73 Billion US$ in 2023. The Eliquis Market Industry is expected to grow from 15.32 Billion US$ in 2024 to 36.87 Billion US$ by 2032. The Eliquis
Eliquis Market Trends, Market Share, Industry Size, Growth, Opportunities and Ma …
The global eliquis market is anticipated to grow at a significant CAGR of 4.8% during the forecast period (2022-2028). Eliquis (apixaban) is a prescription pharmaceutical used to lower the risk of stroke and blood clots in patients with a trial fibrillation, additionally; it lowers the risk of blood clots formation in the legs and lungs of persons who have recently had hip or knee replacement surgery. Apixaban is an anticoagulant
GCC Eliquis Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/gcc-eliquis-market/71801 The global market size of GCC Eliquis is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,